Market News
Stay updated with the latest market trends, earnings, and economic indicators.
NHB probing Aavas Financiers over loan classification lapses
The sector regulator has recalled refinancing support worth nearly Rs 500 crore —a punitive action that has set off a sweeping leadership overhaul at the company. ET was the first to report on April 13 that managing director and CEO Sachinder Bhinder was being asked to step down, with Manu Singh — former home loans head at Kotak Mahindra Bank — set to take over. A week later, on April 20, the company confirmed Bhinder's resignation and Singh's appointment as the new CEO.
Sun Pharmaceutical among 5 Nifty stocks showing bullish RSI upswing
Five Nifty50 stocks featured in the RSI Trending Up scan on June 17 after showing improving momentum. The RSI moved above the 50 mark from lower levels, signalling strengthening price action, improving sentiment and potential short-term buying opportunities for traders tracking bullish technical setups.
HDFC MF, ADIA among buyers as Sepia Investments offloads Rs 749 crore in Corona Remedies via block deal
Sepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged as the largest buyer, while several institutional investors, including Aberdeen entities, ADIA, Invesco and WhiteOak, also accumulated stakes.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Sebi may widen 50% overlap rule to thematic passive mutual fund schemes
Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
Sensex today | Stock Market Live: Sensex down 600 pts, Nifty below 23,200; Max Health, Power Grid, Apollo Hospitals top gainers - BusinessLine
Sensex today | Stock Market Live: Sensex down 600 pts, Nifty below 23,200; Max Health, Power Grid, Apollo Hospitals top gainersBusinessLine
Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block deal
Shares of Alkem Laboratories will be in focus after block deals worth around Rs 930 crore saw 17.88 lakh shares traded at Rs 5,200 apiece on Tuesday. Promoter-linked entities offloaded their stake, while domestic mutual funds and foreign institutional investors emerged as key buyers, signalling strong institutional participation. The company also launched semaglutide pre-filled syringes in India.
Stock Market Crash News Today Live Updates: Nifty Falls Near 23,200, Sensex Declines Over 400 Points; Wockhardt, Schneider Electric Falls 5%
Sectoral indices were mixed in early trade, with Nifty IT rising 2.18% and Nifty Metal gaining 0.13%. On the flipside, Nifty Financial Services fell 1.07%, while Nifty Pharma declined 1.03%.
Sensex Today | Stock Market LIVE Updates: GIFT Nifty extends losses to 200 points; Lenskart in focus
Sensex Today | Stock Market LIVE Updates: The bulls may take comfort from the fact that all recent selling has seen a reversal around this 23,250 - 23,350 range. A break of that level risks further downside for the index. Same is the case with the Nifty Bank, which had another 1,000-point range trading day on Monday.
Ahead of Market: 10 things that will decide stock market action on Monday
Indian equity benchmarks closed modestly higher on Friday, with financial stocks leading the gains. The Nifty and Sensex edged up, though pharma and healthcare weakness capped the rise. Analysts noted the market's indecisive range-bound movement, awaiting a decisive breakout above 23,800 for further upward momentum or a fall towards 23,600.